查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1210983

全球青光眼药物市场规模调查和预测：按药物类别、疾病适应症、分销渠道和地区分析2022-2029

Global Glaucoma Therapeutics Market Size study & Forecast, by Drug Class, By Disease Indication By Distribution Channel and Regional Analysis, 2022-2029
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3个工作天内

价格

青光眼药物是指原发性闭角型 (PAC) 和原发性开角型 (POA) 青光眼的多种替代疗法。

青光眼是一种由视神经结构变化引起的疾病，通常会导致失明和视野缺损。 含有BETA-受体阻滞剂、前列腺素类似物、胆碱能激动剂、碳酸酐□抑製剂、ALPHA-肾上腺素能激动剂等的外用滴眼液主要用于启动青光眼治疗。 这些滴眼液可减少眼内积聚的液体量，从而降低眼内压 (IOP)。 诸如植入式缓释装置、药物洗脱穿刺塞、基于聚合物的隐形眼镜、微针注射装置、微剂量技术等装置的使用，继之以传统手术或激光手术，或两者的组合。你可能会被抓住。 推动市场增长的主要因素之一是全球青光眼发病率的上升。 患有糖尿病、年龄相关性黄斑变性 (AMD)、白内障和干眼症等眼疾的患者患青光眼的机率要高得多。 眼科领域的技术进步也是扩大市场的一个因素，随着产品创新和开发的进步，市场需求有望上升。

预计将推动全球青光眼药物市场增长的主要因素是失明发病率的增加和青光眼患者人数的增加。 据国际防盲协会预测，2020年将有8000万人患有青光眼，比2010年的数据调查增加了约2000万。 此外，预计在预测期内，老年人口的增加将为市场创造有利可图的机会。 然而，主要参与者的药品召回抑制了整个 2022-2029 年预测期内的市场增长。

全球青光眼药物市场研究考虑的主要区域是亚太地区、北美、欧洲、拉丁美洲和世界其他地区。 由于医疗基础设施的改善和青光眼患病率的上升，北美已成为全球市场份额的主导地区。 另一方面，由于糖尿病患病率上升、眼病增加以及盲人和视力受损者人数增加等因素，预计亚太地区在预测期内的增长率将最高。产生有利的增长前景整个青光眼治疗市场。

这项研究的目的是定义近年来各个细分市场和国家的市场规模，并预测未来几年的价值。 该报告旨在捕捉被调查国家工业的定性和定量方面。

它还提供了关键方面的详细信息，例如决定市场未来增长的驱动因素和挑战。 此外，它还包含供利益相关者投资的微观市场潜在机会，以及对主要参与者的竞争格局和产品供应的深入分析。

内容

第 1 章执行摘要

  • 市场概况
  • 2019-2029 年各细分市场的全球市场估计和预测
    • 青光眼药物市场：按地区划分，2019-2029 年
    • 按药物类别划分的青光眼药物市场：2019 年至 2029 年
    • 青光眼药物市场：按疾病适应症分类，2019-2029 年
    • 青光眼药物市场：按分销渠道，2019-2029 年
  • 主要趋势
  • 调查方法
  • 调查先决条件

第 2 章全球青光眼药物市场定义和范围

  • 调查的目的
  • 市场定义和范围
    • 调查范围
    • 工业发展
  • 调查年份
  • 货币兑换率

第3章全球青光眼药物市场动态

  • 青光眼药物市场影响分析（2019-2029）
    • 市场驱动因素
      • 青光眼患病率上升
      • 技术进步的增加
    • 市场挑战
      • 主要参与者的药物召回
    • 市场机会
      • 老年人口增加

第四章青光眼药物全球市场行业分析

  • 波特 5 力模型
    • 供应商的议价能力
    • 买家的议价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争公司之间的敌对关係
  • 波特 5 力模型的未来方法 (2019-2029)
  • 害虫分析
    • 政治
    • 经济的
    • 社交
    • 技术
  • 顶级投资机会
  • 关键成功策略
  • 行业专家的展望
  • 分析师的结论和建议

第 5 章风险评估：COVID-19 的影响

  • 评估 COVID-19 对行业的总体影响
  • COVID-19 之前和 COVID-19 之后的市场情景

第 6 章全球青光眼药物市场：按药物类别分类

  • 市场概况
  • 全球青光眼药物市场：按药物类别、性能潜力分析
  • 全球青光眼药物市场、按药物类别估计和预测 (2019-2029)
  • 青光眼药物市场细分分析
    • BETA受体阻滞剂
    • 前列腺素类似物
    • ALPHA-肾上腺素激动剂
    • 碳酸酐□抑製剂
    • 伴随用药

第 7 章全球青光眼药物市场：按疾病适应症分类

  • 市场概况
  • 全球青光眼药物市场：按疾病适应症进行性能潜力分析
  • 2019-2029 年全球青光眼药物市场、按疾病适应症估计和预测
  • 青光眼药物市场细分分析
    • 开角型青光眼
    • 闭角型青光眼

第 8 章全球青光眼药物市场，按分销渠道

  • 市场概况
  • 全球青光眼药物市场：按分销渠道进行的性能和潜力分析
  • 全球青光眼药物市场、按分销渠道估算和预测 (2019-2029)
  • 青光眼药物市场细分分析
    • 医院药房
    • 零售药房
    • 在线药店

第 9 章全球青光眼药物市场：区域分析

  • 青光眼药物市场，按地区划分的市场概况
  • 北美
    • 美国
      • 2019-2029 年按药物类别的估计和预测
      • 2019-2029 年各疾病适应症的估计和预测
      • 按销售渠道估算和预测，2019 年至 2029 年
    • 加拿大
  • 欧洲青光眼药物市场概况
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 意大利
    • 其他欧洲地区
  • 亚太地区青光眼药物市场概况
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 韩国
    • 其他亚太地区
  • 拉丁美洲青光眼药物市场概况
    • 巴西
    • 墨西哥
    • 其他拉丁美洲地区
  • 世界其他地区

第 10 章衝突信息

  • 顶级市场策略
  • 公司简介
    • Deep Dive
      • 主要信息
      • 概览
      • 财务信息（取决于数据可用性）
      • 产品概述
      • 近期趋势
    • Allergan Plc
    • Merck & Co., Inc.
    • Akorn, Operating Company LLC
    • Bausch & Lomb Incorporated
    • Oculis S.A.
    • Teva Pharmaceuticals Industries Ltd
    • Alcon
    • Pfizer Inc
    • Nanodropper, Inc.

第 11 章研究过程

  • 研究过程
    • 数据挖掘
    • 分析
    • 市场评估
    • 验证
    • 出版
  • 调查属性
  • 调查先决条件

Global Glaucoma Therapeutics Market is valued at approximately USD XXX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Glaucoma therapeutics refers to the various alternative treatments for Primary Angle-Closure (PAC) and Primary Open-Angle (POA) glaucoma. The condition is caused by structural changes in the optic nerves, which frequently lead to blindness and vision loss. Topical eye drops that primarily include beta-blockers, prostaglandin analogues, cholinergic, carbonic anhydrase inhibitors, and alpha-adrenergic agonists can be used to start the treatment for glaucoma. These eye drops decrease the amount of fluid generated in the eyes, reducing intraocular pressure (IOP). The usage of devices such as implantable extended-release devices, drug-eluting punctal plugs, polymer-based contact lenses, microneedle-injection devices, and microdosing technologies can then be followed by traditional or laser surgical procedures or a combination of both. One of the main factors fueling the market's growth is the rising incidence of glaucoma worldwide. Patients with diabetes and other eye conditions, such as Age-Related Macular Degeneration (AMD), cataract, and dry eye, are significantly more probable to develop glaucoma. Also, another factor driving the market growth is increasing technological advancements in the field of ophthalmology and rising product innovation and development is anticipated to create demand for the market.

The key factors projected to fuel the growth of the global glaucoma therapeutics market are the rising occurrences of blindness and the rising numbers of glaucoma patients. The International Agency for the Prevention of Blindness reports that in 2020, 80 million individuals have glaucoma, an increase of nearly 20 million from its 2010 data findings. Additionally, the rising geriatric population is anticipated to create a lucrative opportunity for the market during the forecast period. However, the drug recalls by major players stifled market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Glaucoma Therapeutics Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the dominating region across the world in terms of market share, owing to the well-developed medical infrastructure and rising prevalence of glaucoma in the region. Whereas, Asia Pacific is also anticipated to exhibit the highest growth rate over the forecast period, owing to factors such as the rising prevalence of diabetes, rising ocular disorders, and the growing number of blind and visually impaired people would create lucrative growth prospects for the Glaucoma Therapeutics market across Asia Pacific region.

Major market players included in this report are:

Deep Dive

Allergan Plc

Merck & Co., Inc.

Akorn Operating Company LLC

Bausch & Lomb Incorporated

Oculis S.A.

Teva Pharmaceuticals Industries Ltd

Alcon

Pfizer Inc.

Nanodropper, Inc.

Recent Developments in the Market:

  • In May 2020, AbbVie Inc announced the acquisition of Allergan Plc. Through this AbbVie Inc. has been able to establish itself as a market leader in the glaucoma sector.
  • In Dec. 2019, In Japan, Senju Pharmaceutical Co., Ltd. announced the launch of AIBETA, a combination drug for the treatment of glaucoma and hypertension.

Global Glaucoma Therapeutics Market Report Scope:

Historical Data: 2019-2020-2021

Base Year for Estimation: 2021

Forecast period: 2022-2029

Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered: Drug Class, Disease Indication, Distribution Channel, Region

Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Drug Class:

Beta Blockers

Prostaglandins Analogs

Alpha Adrenergic Agonists

Carbonic Anhydrase Inhibitors

Combination Drugs

By Disease Indication:

Open Angle Glaucoma

Angle Closure Glaucoma

By Distribution Channel:

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

RoLA

Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Glaucoma Therapeutics Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Glaucoma Therapeutics Market, by Drug Class, 2019-2029 (USD Billion)
    • 1.2.3. Glaucoma Therapeutics Market, by Disease Indication, 2019-2029 (USD Billion)
    • 1.2.4. Glaucoma Therapeutics Market, by Distribution Channel, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Glaucoma Therapeutics Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Glaucoma Therapeutics Market Dynamics

  • 3.1. Glaucoma Therapeutics Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Rising incidence of glaucoma
      • 3.1.1.2. Increasing technological advancements
    • 3.1.2. Market Challenges
      • 3.1.2.1. Drug recalls by major players
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rising geriatric population

Chapter 4. Global Glaucoma Therapeutics Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. Industry Experts Prospective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Glaucoma Therapeutics Market, by Drug Class

  • 6.1. Market Snapshot
  • 6.2. Global Glaucoma Therapeutics Market by Drug Class, Performance - Potential Analysis
  • 6.3. Global Glaucoma Therapeutics Market Estimates & Forecasts by Drug Class 2019-2029 (USD Billion)
  • 6.4. Glaucoma Therapeutics Market, Sub Segment Analysis
    • 6.4.1. Beta Blockers
    • 6.4.2. Prostaglandins Analogs
    • 6.4.3. Alpha Adrenergic Agonists
    • 6.4.4. Carbonic Anhydrase Inhibitors
    • 6.4.5. Combination Drugs

Chapter 7. Global Glaucoma Therapeutics Market, by Disease Indication

  • 7.1. Market Snapshot
  • 7.2. Global Glaucoma Therapeutics Market by Disease Indication, Performance - Potential Analysis
  • 7.3. Global Glaucoma Therapeutics Market Estimates & Forecasts by Disease Indication 2019-2029 (USD Billion)
  • 7.4. Glaucoma Therapeutics Market, Sub Segment Analysis
    • 7.4.1. Open Angle Glaucoma
    • 7.4.2. Angle Closure Glaucoma

Chapter 8. Global Glaucoma Therapeutics Market, by Distribution Channel

  • 8.1. Market Snapshot
  • 8.2. Global Glaucoma Therapeutics Market by Distribution Channel, Performance - Potential Analysis
  • 8.3. Global Glaucoma Therapeutics Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Billion)
  • 8.4. Glaucoma Therapeutics Market, Sub Segment Analysis
    • 8.4.1. Hospital Pharmacy
    • 8.4.2. Retail Pharmacy
    • 8.4.3. Online Pharmacy

Chapter 9. Global Glaucoma Therapeutics Market, Regional Analysis

  • 9.1. Glaucoma Therapeutics Market, Regional Market Snapshot
  • 9.2. North America Glaucoma Therapeutics Market
    • 9.2.1. U.S. Glaucoma Therapeutics Market
      • 9.2.1.1. Drug Class breakdown estimates & forecasts, 2019-2029
      • 9.2.1.2. Disease Indication breakdown estimates & forecasts, 2019-2029
      • 9.2.1.3. Distribution Channel breakdown estimates & forecasts, 2019-2029
    • 9.2.2. Canada Glaucoma Therapeutics Market
  • 9.3. Europe Glaucoma Therapeutics Market Snapshot
    • 9.3.1. U.K. Glaucoma Therapeutics Market
    • 9.3.2. Germany Glaucoma Therapeutics Market
    • 9.3.3. France Glaucoma Therapeutics Market
    • 9.3.4. Spain Glaucoma Therapeutics Market
    • 9.3.5. Italy Glaucoma Therapeutics Market
    • 9.3.6. Rest of Europe Glaucoma Therapeutics Market
  • 9.4. Asia-Pacific Glaucoma Therapeutics Market Snapshot
    • 9.4.1. China Glaucoma Therapeutics Market
    • 9.4.2. India Glaucoma Therapeutics Market
    • 9.4.3. Japan Glaucoma Therapeutics Market
    • 9.4.4. Australia Glaucoma Therapeutics Market
    • 9.4.5. South Korea Glaucoma Therapeutics Market
    • 9.4.6. Rest of Asia Pacific Glaucoma Therapeutics Market
  • 9.5. Latin America Glaucoma Therapeutics Market Snapshot
    • 9.5.1. Brazil Glaucoma Therapeutics Market
    • 9.5.2. Mexico Glaucoma Therapeutics Market
    • 9.5.3. Rest of Latin America Glaucoma Therapeutics Market
  • 9.6. Rest of The World Glaucoma Therapeutics Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. Deep Dive
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Product Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. Allergan Plc
    • 10.2.3. Merck & Co., Inc.
    • 10.2.4. Akorn, Operating Company LLC
    • 10.2.5. Bausch & Lomb Incorporated
    • 10.2.6. Oculis S.A.
    • 10.2.7. Teva Pharmaceuticals Industries Ltd
    • 10.2.8. Alcon
    • 10.2.9. Pfizer Inc
    • 10.2.10. Nanodropper, Inc.

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Glaucoma Therapeutics Market, report scope
  • TABLE 2. Global Glaucoma Therapeutics Market estimates & forecasts by Region 2019-2029 (USD Billion)
  • TABLE 3. Global Glaucoma Therapeutics Market estimates & forecasts by Drug Class 2019-2029 (USD Billion)
  • TABLE 4. Global Glaucoma Therapeutics Market estimates & forecasts by Disease Indication 2019-2029 (USD Billion)
  • TABLE 5. Global Glaucoma Therapeutics Market estimates & forecasts by Distribution Channel 2019-2029 (USD Billion)
  • TABLE 6. Global Glaucoma Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Glaucoma Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Glaucoma Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Glaucoma Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Glaucoma Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Glaucoma Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Glaucoma Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Glaucoma Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. Global Glaucoma Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. Global Glaucoma Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 16. U.S. Glaucoma Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 17. U.S. Glaucoma Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 18. U.S. Glaucoma Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 19. Canada Glaucoma Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 20. Canada Glaucoma Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 21. Canada Glaucoma Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 22. UK Glaucoma Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 23. UK Glaucoma Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 24. UK Glaucoma Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 25. Germany Glaucoma Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 26. Germany Glaucoma Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 27. Germany Glaucoma Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 28. France Glaucoma Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 29. France Glaucoma Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 30. France Glaucoma Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 31. Italy Glaucoma Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 32. Italy Glaucoma Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 33. Italy Glaucoma Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 34. Spain Glaucoma Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 35. Spain Glaucoma Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 36. Spain Glaucoma Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 37. RoE Glaucoma Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 38. RoE Glaucoma Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 39. RoE Glaucoma Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 40. China Glaucoma Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 41. China Glaucoma Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 42. China Glaucoma Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 43. India Glaucoma Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 44. India Glaucoma Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 45. India Glaucoma Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 46. Japan Glaucoma Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 47. Japan Glaucoma Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 48. Japan Glaucoma Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 49. South Korea Glaucoma Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 50. South Korea Glaucoma Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 51. South Korea Glaucoma Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 52. Australia Glaucoma Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 53. Australia Glaucoma Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 54. Australia Glaucoma Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC Glaucoma Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 56. RoAPAC Glaucoma Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 57. RoAPAC Glaucoma Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 58. Brazil Glaucoma Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 59. Brazil Glaucoma Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 60. Brazil Glaucoma Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 61. Mexico Glaucoma Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 62. Mexico Glaucoma Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 63. Mexico Glaucoma Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 64. RoLA Glaucoma Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 65. RoLA Glaucoma Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 66. RoLA Glaucoma Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 67. Row Glaucoma Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 68. Row Glaucoma Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 69. Row Glaucoma Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 70. List of secondary sources, used in the study of global Glaucoma Therapeutics Market
  • TABLE 71. List of primary sources, used in the study of global Glaucoma Therapeutics Market
  • TABLE 72. Years considered for the study
  • TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Glaucoma Therapeutics Market, research methodology
  • FIG 2. Global Glaucoma Therapeutics Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Glaucoma Therapeutics Market, key trends 2021
  • FIG 5. Global Glaucoma Therapeutics Market, growth prospects 2022-2029
  • FIG 6. Global Glaucoma Therapeutics Market, porters 5 force model
  • FIG 7. Global Glaucoma Therapeutics Market, pest analysis
  • FIG 8. Global Glaucoma Therapeutics Market, value chain analysis
  • FIG 9. Global Glaucoma Therapeutics Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Glaucoma Therapeutics Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Glaucoma Therapeutics Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Glaucoma Therapeutics Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Glaucoma Therapeutics Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Glaucoma Therapeutics Market, regional snapshot 2019 & 2029
  • FIG 15. North America Glaucoma Therapeutics Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Glaucoma Therapeutics Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia pacific Glaucoma Therapeutics Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Glaucoma Therapeutics Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Glaucoma Therapeutics Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable